Form 4: Solid Biosciences' Chief Regulatory Officer Granted Restricted Stock Units

Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences Inc., was granted 110,500 restricted stock units (RSUs) on January 31, 2025, vesting over four years.

Summary

• Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences Inc., filed a Form 4 on February 11, 2025, reporting a transaction.
• On January 31, 2025, Hanrahan was granted 110,500 restricted stock units (RSUs) that vest over four years.
• 25% of the RSUs will vest on each anniversary of the grant date.
• Each RSU represents a contingent right to receive one share of Solid Biosciences' common stock.
• Hanrahan also provided a Limited Power of Attorney to Kimberly Cornwell to handle Section 16 reporting obligations.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating a stable and ongoing operation. The sentiment is neutral to positive as it suggests continued investment in key personnel.

Positives

• The grant of RSUs to the Chief Regulatory Officer aligns her interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the officer.

Future Outlook

The vesting of the RSUs will occur over the next four years, incentivizing the officer's continued service and contribution to the company.

Industry Context

Granting stock-based compensation is a common practice in the biotechnology industry to attract and retain key personnel and align their interests with those of the shareholders.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation tools in the biotech industry, used by companies like Sarepta Therapeutics and BioMarin Pharmaceutical to incentivize executives.
• The vesting schedule of four years is also typical, aligning with industry norms for long-term retention.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the Chief Regulatory Officer to contribute to the company's success.
• Employees may see this as a positive sign of investment in leadership.

Next Steps

• The RSUs will continue to vest annually over the next four years.
• Kimberly Cornwell will act as attorney-in-fact for Section 16 reporting obligations.

Key Dates